204 Combining FT536, a Pan-Tumor Targeting CAR NK Cell Therapy, with CD16 Engagers Provides a Coordinated Targeting Strategy to Overcome Tumor Heterogeneity

Regular and Young Investigator Award Abstracts(2022)

引用 0|浏览26
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要